Encore Presentations
Monday, November 13, 2023
01:00 PM–02:30 PM
Abstract
Crushing valbenazine capsule contents for potential addition to soft foods
or administration via G‑tube
Mello Hebert, Alexander Mar, Richard Moore, Ali Bristow, Brittany
Harbert, Scott Siegert
Neurocrine
Biosciences, Inc., San Diego, CA
ABSTRACT
Background: Once-daily valbenazine
is FDA-approved for tardive dyskinesia and undergoing clinical evaluation for
chorea associated with Huntington disease and dyskinetic cerebral palsy.
Dysphagia can occur with these disorders, making it difficult to swallow whole
medications. Three studies were conducted to evaluate the suitability of mixing
crushed contents from valbenazine capsules (40 and 80 mg) with soft foods/liquids
or delivering them in water via gastrostomy tube (G-tube).
Methods: In Study 1, whole
valbenazine capsules and crushed capsule contents were dissolved in a warm
solution. Samples were collected serially over 1 hour for analysis. In Study 2,
crushed contents from valbenazine capsules (both doses) were mixed into
applesauce, yogurt, and pudding; crushed contents (40 mg) were also added to
buffer solutions (pH 1.2, 4.5, 6.8) and fed-state simulated gastric fluid (FeSSGF). In Study 3, crushed valbenazine capsule contents (both
doses) were dispersed in tap water (~0° to 50°C) and
added to a G-tube, with and without a cup rinse. In Studies 2 and 3, conditions
that yielded 90-110% valbenazine recovery were considered acceptable for
administration.
Results: In Study 1, rapid
and complete drug release (>98% in 15 min) was observed in all samples,
independent of preparation (whole capsules, crushed contents) or dose (40 mg,
80 mg). In Study 2, valbenazine recovery was acceptable within 2 hours of adding
crushed contents to tested foods, buffers, or FeSSGF (recovery
range: 92-102%), with minimal degradants detected. In Study 3, valbenazine
recovery was acceptable when crushed capsule contents were dispersed in hot or
cold water and a cup rinse was performed (recovery range: 91-97%).
Conclusions: Crushing valbenazine
capsule contents did not impact in vitro dissolution performance. Mixing the contents
with soft foods/liquids or delivering them in tap water via G‑tube may be
acceptable methods for administering valbenazine to patients who have
difficulty swallowing.
Presenting Author
Brittany Harbert PharmDNeurocrine Biosciences, Inc.
Authors
Ali Bristow MS
Neurocrine Biosciences, Inc.
Alexander Mar BS
Neurocrine Biosciences, Inc.
Mello Hebert BS
Neurocrine Biosciences, Inc.
Richard Moore MBA
Neurocrine Biosciences, Inc.
Scott Siegert PharmD
Neurocrine Biosciences, Inc.